UNI-EN 73:Consolidated financial report of Sopharma Group for the first half of 2018
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 73 | / | 2018 | |||||||
| Date of issue: | 2018-08-29 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Consolidated financial report of Sopharma Group for the first half of 2018 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| 1. Financial report according to IFRS as at 30 June 2018 2. Notes to the financial report as at 30 June 2018 3. Management report as at 30 June 2018 4. Insider information as at 30 June 2018 5. Additional information as at 30 June 2018 6. Financial report according to BFCS standards as at 30 June 2018 7. Annex 9 as at 30 June 2018 8. Declaration as at 30 June 2018 | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Consolidated financial report of Sopharma Group for the first half of 2018.zip Consolidated financial report of Sopharma Group for the first half of 2018.zip | Consolidated financial report of Sopharma Group for the first half of 2018 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2018-08-29 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.75 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
